Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

128.91 +0.04 (+0.03%)
Streaming Delayed Price Updated: 10:07 AM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 Next >
4 Analysts Assess GeneDx Holdings: What You Need To Know
 
Via Benzinga
This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case
GeneDx stock shows strong growth momentum with 600% EPS growth and a bullish technical setup, signaling a potential breakout for investors. 
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Positive Technical Setup
GeneDx (WGS) shows explosive growth with 600% EPS growth and a strong technical uptrend, making it a top high-growth momentum stock for investors. 
Via Chartmill
Earnings Scheduled For July 29, 2025
 
Via Benzinga
Exploring GeneDx Hldgs's Earnings Expectations
 
Via Benzinga
Assessing GeneDx Holdings: Insights From 5 Financial Analysts
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Why GeneDx Holdings Stock Crushed It Again Today
It continued to ride high on its solid second-quarter performance. 
Via The Motley Fool
What 4 Analyst Ratings Have To Say About GeneDx Holdings
 
Via Benzinga
Why GeneDx Holdings Stock Blasted 8% Higher Today
There's nothing like a crushing double beat on quarterly results to give some life to a stock. 
Via The Motley Fool
Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Technical Strength for Potential Upside
GeneDx Holdings Corp (WGS) shows strong earnings & revenue growth, positive analyst revisions, and solid technicals, making it a high-growth momentum stock with breakout potential. 
Via Chartmill
GeneDx CFO Sells More Than Half of His Shares
Via The Motley Fool
Topics Artificial Intelligence
Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories? 
Via MarketBeat
Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts
 
Via Benzinga
Why GeneDX Stock Surged Higher This Week
Via The Motley Fool
Why GeneDx, An IBD 50 Stock, Has Skyrocketed 34% Over The Past Two Days
There's a new recommendation on genetic testing for children, and this stock is on the rise. 
Via Investor's Business Daily
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Analyst Expectations For GeneDx Holdings's Future
 
Via Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
 
Via Benzinga
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Via The Motley Fool
Retail Buzz Swirls Around GeneDx As Shares Sink 43% Despite Earnings Beat
GeneDx shares plunged 43% despite strong Q1 results and raised guidance, drawing a surge in retail investor interest. The drop followed the company's first sequential test volume decline, which it... 
Via Stocktwits
Wednesday's session: top gainers and losers
Intrigued by the market activity one hour before the close of the markets on Wednesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
Top stock movements in today's session.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.